Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Alopecia areata patients have lower vitamin D levels than healthy individuals.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

COVID-19 doesn't make alopecia areata worse.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

PRP treatment may help with alopecia areata, especially in newer cases.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.